Marco Migliardi

786 total citations
40 papers, 576 citations indexed

About

Marco Migliardi is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Marco Migliardi has authored 40 papers receiving a total of 576 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 11 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Genetics. Recurrent topics in Marco Migliardi's work include Acute Myocardial Infarction Research (7 papers), Thyroid Disorders and Treatments (6 papers) and Atrial Fibrillation Management and Outcomes (5 papers). Marco Migliardi is often cited by papers focused on Acute Myocardial Infarction Research (7 papers), Thyroid Disorders and Treatments (6 papers) and Atrial Fibrillation Management and Outcomes (5 papers). Marco Migliardi collaborates with scholars based in Italy, United Kingdom and Spain. Marco Migliardi's co-authors include Aldo Clerico, Nicoletta Ravarino, Ruggero Dittadi, Andrea Padoan, Martina Zaninotto, Mario Plebani, Riccardo Ponzone, Concetta Prontera, Paola Sgandurra and Nicoletta Biglia and has published in prestigious journals such as Gastroenterology, Clinica Chimica Acta and Breast Cancer Research and Treatment.

In The Last Decade

Marco Migliardi

39 papers receiving 551 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco Migliardi Italy 15 218 173 84 83 77 40 576
Serkan Bulur Türkiye 18 291 1.3× 127 0.7× 21 0.3× 101 1.2× 47 0.6× 42 668
Egil Henriksen Sweden 16 363 1.7× 54 0.3× 38 0.5× 107 1.3× 148 1.9× 35 735
Huimin Zhang China 17 202 0.9× 139 0.8× 64 0.8× 248 3.0× 21 0.3× 87 938
Mansour Taghavi Azar Sharabiani United Kingdom 11 255 1.2× 118 0.7× 30 0.4× 391 4.7× 41 0.5× 22 774
Foteini Kousathana Greece 11 187 0.9× 205 1.2× 26 0.3× 85 1.0× 29 0.4× 18 544
Eduardo de Teresa–Galván Spain 17 542 2.5× 82 0.5× 58 0.7× 195 2.3× 78 1.0× 72 744
Abdullah Alshehri Saudi Arabia 11 104 0.5× 74 0.4× 36 0.4× 103 1.2× 38 0.5× 49 393
Atakan Yeşıl Türkiye 13 77 0.4× 169 1.0× 84 1.0× 126 1.5× 18 0.2× 26 750
Anne Mercadier France 15 211 1.0× 173 1.0× 16 0.2× 131 1.6× 24 0.3× 26 1.3k
Alessandra Fanelli Italy 11 99 0.5× 93 0.5× 26 0.3× 90 1.1× 18 0.2× 48 505

Countries citing papers authored by Marco Migliardi

Since Specialization
Citations

This map shows the geographic impact of Marco Migliardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Migliardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Migliardi more than expected).

Fields of papers citing papers by Marco Migliardi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Migliardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Migliardi. The network helps show where Marco Migliardi may publish in the future.

Co-authorship network of co-authors of Marco Migliardi

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Migliardi. A scholar is included among the top collaborators of Marco Migliardi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Migliardi. Marco Migliardi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clerico, Aldo, Martina Zaninotto, Claudio Galli, et al.. (2024). Assessment of cardiovascular risk and physical activity: the role of cardiac-specific biomarkers in the general population and athletes. Clinical Chemistry and Laboratory Medicine (CCLM). 63(1). 71–86. 3 indexed citations
2.
Clerico, Aldo, Martina Zaninotto, Andrea Padoan, et al.. (2020). Harmonization of two hs-cTnI methods based on recalibration of measured quality control and clinical samples. Clinica Chimica Acta. 510. 150–156. 15 indexed citations
3.
Clerico, Aldo, Martina Zaninotto, Claudio Passino, et al.. (2020). High-sensitivity methods for cardiac troponins: The mission is not over yet. Advances in clinical chemistry. 103. 215–252. 20 indexed citations
4.
5.
Clerico, Aldo, Andrea Ripoli, Silvia Masotti, et al.. (2019). Evaluation of 99th percentile and reference change values of a high-sensitivity cTnI method: A multicenter study. Clinica Chimica Acta. 493. 156–161. 27 indexed citations
6.
Dittadi, Ruggero, Silvia Masotti, Concetta Prontera, et al.. (2017). Multicenter evaluation of the new immunoassay method for TSH measurement using the automated DxI platform. Clinica Chimica Acta. 468. 105–110. 8 indexed citations
7.
Clerico, Aldo, Andrea Ripoli, Antonio Fortunato, et al.. (2017). Harmonization protocols for TSH immunoassays: a multicenter study in Italy. Clinical Chemistry and Laboratory Medicine (CCLM). 55(11). 1722–1733. 23 indexed citations
8.
Aspromonte, Nadia, Michele Massimo Gulizia, Aldo Clerico, et al.. (2017). ANMCO/ELAS/SIBioC Consensus Document: biomarkers in heart failure. European Heart Journal Supplements. 19(suppl_D). D102–D112. 14 indexed citations
9.
Aspromonte, Nadia, Michele Massimo Gulizia, Aldo Clerico, et al.. (2016). Documento di consenso ANMCO/ELAS/SIBioC: Raccomandazioni sull’impiego dei biomarcatori cardiaci nello scompenso cardiaco. Giornale italiano di cardiologia. 17(9). 615–656. 3 indexed citations
10.
Daperno, Marco, et al.. (2015). Clinical relevance and inter-test reliability of anti-infliximab antibodies and infliximab trough levels in patients with inflammatory bowel disease. Digestive and Liver Disease. 48(2). 138–143. 16 indexed citations
11.
Montaruli, Barbara, Corrado Vitale, Silvia Berutti, et al.. (2015). Dabigatran overdose. Blood Coagulation & Fibrinolysis. 26(2). 225–229. 8 indexed citations
12.
Russolillo, Nadia, Alessandro Ferrero, Luca Viganò, et al.. (2014). Impact of perioperative symbiotic therapy on infectious morbidity after Hpb Surgery in jaundiced patients: a randomized controlled trial. Updates in Surgery. 66(3). 203–210. 9 indexed citations
13.
Daperno, Marco, M. Fracchia, E. Ercole, et al.. (2013). P.08.7 CLINICAL IMPLICATIONS AND STABILITY OF DETERMINATION OF INFLIXIMAB TROUGH LEVELS (IFX-TL) AND ANTIBODIES TO INFLIXIMAB (ATI) IN INFLAMMATORY BOWEL DISEASE. Digestive and Liver Disease. 45. S145–S145. 1 indexed citations
14.
Mormile, Alberto, et al.. (2005). Evaluation of polyethylene glycol precipitation as screening test for macroprolactinemia using Architect immunoanalyser. Immuno-analyse & Biologie Spécialisée. 20(6). 402–407. 5 indexed citations
15.
16.
Giraudi, Gianfranco, et al.. (1988). Effect of tracer binding to serum proteins on the reliability of a direct free testosterone assay. Steroids. 52(4). 423–424. 9 indexed citations
17.
Migliardi, Marco, et al.. (1988). Biological significance of salivary androgens. Steroids. 52(4). 375–376. 1 indexed citations
18.
Costa, Alex Matos da Silva, et al.. (1978). Iodine content of human tissues after administration of iodine containing drugs or contrast media. Journal of Endocrinological Investigation. 1(3). 221–225. 19 indexed citations
19.
Migliardi, Marco, et al.. (1977). ENDEMIC GOITRE IN ALTO ADIGE (ITALY). European Journal of Endocrinology. 85(2). 325–334. 3 indexed citations
20.
Migliardi, Marco, et al.. (1976). A comparison between certain features of endemic goitre in Nepal and Piedmont.. PubMed. 18(7-8). 247–50. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Serkan Bulur Breakdown of academic impact, for papers by Egil Henriksen Breakdown of academic impact, for papers by Huimin Zhang Breakdown of academic impact, for papers by Mansour Taghavi Azar Sharabiani Breakdown of academic impact, for papers by Foteini Kousathana Breakdown of academic impact, for papers by Eduardo de Teresa–Galván Breakdown of academic impact, for papers by Abdullah Alshehri Breakdown of academic impact, for papers by Atakan Yeşıl Breakdown of academic impact, for papers by Anne Mercadier Breakdown of academic impact, for papers by Alessandra Fanelli
Rankless by CCL
2026